These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27152476)

  • 1. Immunogenicity and protective efficacy of Pseudomonas aeruginosa type a and b flagellin vaccines in a burned mouse model.
    Laghaei P; Hashemi FB; Irajian G; Korpi F; Amirmozafari N; Behrouz B
    Mol Immunol; 2016 Jun; 74():71-81. PubMed ID: 27152476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model.
    Korpi F; Hashemi FB; Irajian G; Fatemi MJ; Laghaei P; Behrouz B
    Immunol Lett; 2016 Aug; 176():8-17. PubMed ID: 27210422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
    Bakht Azad S; Nikokar I; Faezi S; Rasooly S; Mahdavi M
    Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
    APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bivalent flagellin immunotherapy protects mice against Pseudomonas aeruginosa infections in both acute pneumonia and burn wound models.
    Ahmadi H; Behrouz B; Irajian G; Amirmozafari N; Naghavi S
    Biologicals; 2017 Mar; 46():29-37. PubMed ID: 28065582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis.
    Faezi S; Sattari M; Mahdavi M; Roudkenar MH
    Burns; 2011 Aug; 37(5):865-72. PubMed ID: 21334822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of Pseudomonas aeruginosa recombinant b-type fagellin as a vaccine candidate: Protective efficacy in a murine burn wound sepsis model.
    Behrouz B; Mahdavi M; Amirmozafari N; Fatemi MJ; Irajian G; Bahroudi M; Hashemi FB
    Burns; 2016 May; ():. PubMed ID: 27156804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa.
    Weimer ET; Ervin SE; Wozniak DJ; Mizel SB
    Vaccine; 2009 Nov; 27(48):6762-9. PubMed ID: 19744586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with Bivalent Flagellin Protects Mice against Fatal
    Behrouz B; Hashemi FB; Fatemi MJ; Naghavi S; Irajian G; Halabian R; Imani Fooladi AA
    J Immunol Res; 2017; 2017():5689709. PubMed ID: 29201922
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-flagellin IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound murine models in a non-type-specific mode.
    Ahmadi TS; Mousavi Gargari SL; Talei D
    Mol Immunol; 2021 Aug; 136():118-127. PubMed ID: 34130152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
    Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
    J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A trivalent vaccine consisting of "flagellin A+B and pilin" protects against Pseudomonas aeruginosa infection in a murine burn model.
    Hashemi FB; Behrouz B; Irajian G; Laghaei P; Korpi F; Fatemi MJ
    Microb Pathog; 2020 Jan; 138():103697. PubMed ID: 31465785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective efficacy of recombinant exotoxin A--flagellin fusion protein against Pseudomonas aeruginosa infection.
    Farajnia S; Peerayeh SN; Tanomand A; Majidi J; Goudarzi G; Naghili B; Rahbarnia L
    Can J Microbiol; 2015 Jan; 61(1):60-4. PubMed ID: 25496361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.
    Weimer ET; Lu H; Kock ND; Wozniak DJ; Mizel SB
    Infect Immun; 2009 Jun; 77(6):2356-66. PubMed ID: 19349426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
    Barnea Y; Carmeli Y; Gur E; Kuzmenko B; Gat A; Neville LF; Eren R; Dagan S; Navon-Venezia S
    Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of pilin protein with alum+naloxone adjuvant against acute pulmonary Pseudomonas aeruginosa infection.
    Banadkoki AZ; Keshavarzmehr M; Afshar Z; Aleyasin N; Fatemi MJ; Behrouz B; Hashemi FB
    Biologicals; 2016 Sep; 44(5):367-73. PubMed ID: 27427517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies raised against divalent type b flagellin and pilin provide effective immunotherapy against Pseudomonas aeruginosa infection of mice with burn wounds.
    Saffari M; Behbood S; Irajian G; Khorshidi A; Moniri R; Behrouz B
    Biologicals; 2017 Jan; 45():20-26. PubMed ID: 27836582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with 3-oxododecanoyl-L-homoserine lactone-r-PcrV conjugate enhances survival of mice against lethal burn infections caused by Pseudomonas aeruginosa.
    Golpasha ID; Mousavi SF; Owlia P; Siadat SD; Irani S
    Bosn J Basic Med Sci; 2015 May; 15(2):15-24. PubMed ID: 26042508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-Silico Analysis and Protective Efficacy of the PcrV Recombinant Vaccine against Pseudomonas Aeruginosa in the Burned and PA-Infected BALB/c Mouse Model.
    Fakoor MH; Owlia P; Mousavi Gargari SL; Sabokbar A
    Iran J Immunol; 2020 Jun; 17(2):121-136. PubMed ID: 32602466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy with anti-flagellin A monoclonal antibody limits Pseudomonas aeruginosa invasiveness in a mouse burn wound sepsis model.
    Barnea Y; Carmeli Y; Neville LF; Kahel-Reifer H; Eren R; Dagan S; Navon-Venezia S
    Burns; 2009 May; 35(3):390-6. PubMed ID: 18951715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.